Lisanti Capital Growth, LLC Pacira Bio Sciences, Inc. Transaction History

Lisanti Capital Growth, LLC

$384 Million
Q2 2024

A detailed history of Lisanti Capital Growth, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Lisanti Capital Growth, LLC holds 138,830 shares of PCRX stock, worth $2.02 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

138,830

Holding current value

$2.02 Million

% of portfolio

1.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$25.5 - $31.51 $3.54 Million - $4.37 Million	138,830 New	138,830 $3.97 Million
Q2 2022 Aug 03, 2022	SELL	$51.49 - $81.64 $8.83 Million - $14 Million	-171,540 Reduced 56.72%	130,873 $7.63 Million
Q1 2022 May 12, 2022	BUY	$60.03 - $76.49 $10.7 Million - $13.6 Million	178,428 Added 143.91%	302,413 $23.1 Million
Q4 2021 Feb 04, 2022	BUY	$47.97 - $62.21 $4.42 Million - $5.73 Million	92,060 Added 288.36%	123,985 $7.46 Million
Q3 2021 Nov 03, 2021	BUY	$54.64 - $61.3 $576,998 - $647,328	10,560 Added 49.43%	31,925 $1.79 Million
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $9.57 Million - $11.3 Million	-161,740 Reduced 88.33%	21,365 $1.3 Million
Q1 2021 May 12, 2021	BUY	$59.31 - $78.82 $10.9 Million - $14.4 Million	183,105 New	183,105 $12.8 Million
Q4 2020 Feb 10, 2021	SELL	$50.47 - $66.26 $8.5 Million - $11.2 Million	-168,482 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$51.97 - $63.0 $4,885 - $5,922	94 Added 0.06%	168,482 $10.1 Million
Q2 2020 Aug 10, 2020	BUY	$30.8 - $52.47 $1.84 Million - $3.13 Million	59,709 Added 54.94%	168,388 $8.84 Million
Q1 2020 May 11, 2020	BUY	$28.4 - $50.7 $157,052 - $280,371	5,530 Added 5.36%	108,679 $3.64 Million
Q4 2019 Feb 13, 2020	BUY	$36.31 - $46.83 $282,455 - $364,290	7,779 Added 8.16%	103,149 $4.67 Million
Q3 2019 Nov 06, 2019	SELL	$35.66 - $44.99 $829,094 - $1.05 Million	-23,250 Reduced 19.6%	95,370 $3.63 Million
Q2 2019 Aug 05, 2019	BUY	$36.57 - $47.97 $1.7 Million - $2.24 Million	46,615 Added 64.74%	118,620 $5.16 Million
Q1 2019 May 13, 2019	SELL	$36.47 - $42.17 $1.14 Million - $1.32 Million	-31,185 Reduced 30.22%	72,005 $2.74 Million
Q4 2018 Feb 08, 2019	BUY	$41.31 - $52.16 $1.76 Million - $2.22 Million	42,575 Added 70.24%	103,190 $4.44 Million
Q3 2018 Nov 05, 2018	BUY	$32.85 - $52.0 $1.99 Million - $3.15 Million	60,615 New	60,615 $2.98 Million

Others Institutions Holding PCRX

# of Institutions

301

Shares Held

51.5M

Call Options Held

378K

Put Options Held

1.53M

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $666M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.

Account

Lisanti Capital Growth, LLC Pacira Bio Sciences, Inc. Transaction History